A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 50,094 followers.

A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report: Relapsed/refractory ovarian cancer, especially platinum resistance… #immunology https://t.co/1tJ5XDuhq5

11 Oct 2022

Reply Repost Favourite

New Research: A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report: Relapsed/refractory ovarian cancer, especially platinum resistance… https://t.co/f304VIhJv

07 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.